17 September 2020

Cross-Border Conversions within the EU are bound for Change: Main Takeaways

Due to the absence of harmonized rules, cross-border migrations have a long history of jurisprudence within the EU. Directive 2019/2121 aims at creating a common legal framework for EU cross-border conversions and divisions.

The new legal framework, to be implemented into national laws by 31 January 2023, will increase legal certainty within the EU and benefit employees, shareholders and creditors. However, for the companies and intragroup re-structurings, the new regime could be more burdensome than the current legal solutions. Migrations with a non-EU country will continue to be challenging. As a consequence of Brexit, the UK will likely fall out of the scope of the European jurisprudence after 31 December 2020.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 03.08.2021

    GSK Update: Cross-Border Distribution Directive implemented – What you should know

    Read more
  • 07.05.2021

    GSK Update: Introducing the new sustainable finance measures of the EU Commission

    Read more
  • 30.03.2021

    GSK Update: SFDR – new RTS – What you should know

    Read more
Contact person

Dr. Philipp Mössner, LL.M.

Partner

+352 271802-40

philipp.moessner@gsk-lux.com

Anna Lindner

Senior Associate

+352 271802-43

anna.lindner@gsk-lux.com

© GSK Stockmann 2021